<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.feedburner.com/~d/styles/itemcontent.css"?><rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:wfw="http://wellformedweb.org/CommentAPI/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0"> <channel><title>Polymyalgia Rheumatica</title> <link>http://www.polymyalgia-rheumatica.com</link> <description>polymyalgia rheumatica causes, symptoms, diagnosis, treatment news, info and discussion</description> <lastBuildDate>Sat, 01 Oct 2011 09:06:42 +0000</lastBuildDate> <language>en</language> <sy:updatePeriod>hourly</sy:updatePeriod> <sy:updateFrequency>1</sy:updateFrequency> <generator>http://wordpress.org/?v=3.2.1</generator> <xhtml:meta xmlns:xhtml="http://www.w3.org/1999/xhtml" name="robots" content="noindex" /> <atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://feeds.feedburner.com/PolymyalgiaRheumatica" /><feedburner:info uri="polymyalgiarheumatica" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><feedburner:emailServiceId>PolymyalgiaRheumatica</feedburner:emailServiceId><feedburner:feedburnerHostname>http://feedburner.google.com</feedburner:feedburnerHostname><item><title>Treatment of Polymyalgia Rheumatica: A Systematic Review [Review Article]</title><link>http://feedproxy.google.com/~r/PolymyalgiaRheumatica/~3/hwBGqAUTLlM/treatment-of-polymyalgia-rheumatica-a-systematic-review-review-article.html</link> <comments>http://www.polymyalgia-rheumatica.com/treatment-of-polymyalgia-rheumatica-a-systematic-review-review-article.html#comments</comments> <pubDate>Sat, 01 Oct 2011 09:06:42 +0000</pubDate> <dc:creator>wildplus</dc:creator> <category><![CDATA[Uncategorized]]></category> <category><![CDATA[article]]></category> <category><![CDATA[Polymyalgia]]></category> <category><![CDATA[review]]></category> <category><![CDATA[Rheumatica]]></category> <category><![CDATA[systematic]]></category> <category><![CDATA[Treatment]]></category> <guid isPermaLink="false">http://www.polymyalgia-rheumatica.com/treatment-of-polymyalgia-rheumatica-a-systematic-review-review-article</guid> <description>Conclusions&amp;#160; The scarcity of randomized trials and the high level of heterogeneity of studies on PMR therapy do not allow firm conclusions to be drawn. However, PMR remission seems to be achieved with prednisone treatment at a dose of 15 mg/d in most patients, and reductions below 10 mg/d should preferably follow a tapering rate [...]
Related posts:&lt;ol&gt;&lt;li&gt;&lt;a
href='http://www.polymyalgia-rheumatica.com/systematic-review-treatment-of-polymyalgia-rheumatica.html' rel='bookmark' title='Systematic review: Treatment of polymyalgia rheumatica'&gt;Systematic review: Treatment of polymyalgia rheumatica&lt;/a&gt; &lt;small&gt;Source: Arch Internal Med Area: News A systematic review of the evidence on treatment of polymyalgia rheumatica concludes that there...&lt;/small&gt;&lt;/li&gt;&lt;li&gt;&lt;a
href='http://www.polymyalgia-rheumatica.com/the-correct-prednisone-starting-dose-in-polymyalgia-rheumatica-is-related-to-body-weight-but-not-to-disease-severity-2.html' rel='bookmark' title='The correct prednisone starting dose in polymyalgia rheumatica is related to body weight but not to disease severity'&gt;The correct prednisone starting dose in polymyalgia rheumatica is related to body weight but not to disease severity&lt;/a&gt; &lt;small&gt;Conclusions: 12.5 mg prednisone is a sufficient starting dose in of PMR patients. The main factor driving response to prednisone...&lt;/small&gt;&lt;/li&gt;&lt;li&gt;&lt;a
href='http://www.polymyalgia-rheumatica.com/the-correct-prednisone-starting-dose-in-polymyalgia-rheumatica-is-related-to-body-weight-but-not-to-disease-severity.html' rel='bookmark' title='The correct prednisone starting dose in polymyalgia rheumatica is related to body weight but not to disease severity'&gt;The correct prednisone starting dose in polymyalgia rheumatica is related to body weight but not to disease severity&lt;/a&gt; &lt;small&gt;Conclusions: 12.5 mg prednisone is a sufficient starting dose in of PMR patients. The main factor driving response to prednisone...&lt;/small&gt;&lt;/li&gt;&lt;li&gt;&lt;a
href='http://www.polymyalgia-rheumatica.com/changes-in-adiponectin-and-leptin-concentrations-during-glucocorticoid-treatment-a-pilot-study-in-patients-with-polymyalgia-rheumatica.html' rel='bookmark' title='Changes in adiponectin and leptin concentrations during glucocorticoid treatment: a pilot study in patients with polymyalgia rheumatica'&gt;Changes in adiponectin and leptin concentrations during glucocorticoid treatment: a pilot study in patients with polymyalgia rheumatica&lt;/a&gt; &lt;small&gt;This study is concerned with an evaluation of the effects of glucocorticoids (GC) on adiponectin and leptin concentrations in patients...&lt;/small&gt;&lt;/li&gt;&lt;li&gt;&lt;a
href='http://www.polymyalgia-rheumatica.com/diagnostic-performance-of-18f-fluorodeoxyglucose-positron-emission-tomography-in-giant-cell-arteritis-a-systematic-review-and-meta-analysis.html' rel='bookmark' title='Diagnostic performance of 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a systematic review and meta-analysis'&gt;Diagnostic performance of 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a systematic review and meta-analysis&lt;/a&gt; &lt;small&gt;Conclusion&amp;nbsp;&amp;nbsp;We found overall valuable diagnostic performances for FDG PET against reference criteria. Standardized FDG uptake criteria are needed to optimize...&lt;/small&gt;&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/fwO98uwM-KVmzDxWCkAx98I97yQ/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/fwO98uwM-KVmzDxWCkAx98I97yQ/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/fwO98uwM-KVmzDxWCkAx98I97yQ/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/fwO98uwM-KVmzDxWCkAx98I97yQ/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/PolymyalgiaRheumatica/~4/hwBGqAUTLlM" height="1" width="1"/&gt;</description> <wfw:commentRss>http://www.polymyalgia-rheumatica.com/treatment-of-polymyalgia-rheumatica-a-systematic-review-review-article.html/feed/</wfw:commentRss> <slash:comments>0</slash:comments> <feedburner:origLink>http://www.polymyalgia-rheumatica.com/treatment-of-polymyalgia-rheumatica-a-systematic-review-review-article.html</feedburner:origLink></item> <item><title>An evaluation of the impact of seniors on a rheumatology referral clinic: demographics and pharmacotherapy</title><link>http://feedproxy.google.com/~r/PolymyalgiaRheumatica/~3/IEo48Y3PUek/an-evaluation-of-the-impact-of-seniors-on-a-rheumatology-referral-clinic-demographics-and-pharmacotherapy.html</link> <comments>http://www.polymyalgia-rheumatica.com/an-evaluation-of-the-impact-of-seniors-on-a-rheumatology-referral-clinic-demographics-and-pharmacotherapy.html#comments</comments> <pubDate>Thu, 29 Sep 2011 07:08:42 +0000</pubDate> <dc:creator>wildplus</dc:creator> <category><![CDATA[Uncategorized]]></category> <category><![CDATA[clinic]]></category> <category><![CDATA[demographics]]></category> <category><![CDATA[evaluation]]></category> <category><![CDATA[impact]]></category> <category><![CDATA[pharmacotherapy]]></category> <category><![CDATA[referral]]></category> <category><![CDATA[Rheumatology]]></category> <category><![CDATA[seniors]]></category> <guid isPermaLink="false">http://www.polymyalgia-rheumatica.com/an-evaluation-of-the-impact-of-seniors-on-a-rheumatology-referral-clinic-demographics-and-pharmacotherapy</guid> <description>This study highlights the need for reciprocal knowledge by both geriatricians and rheumatologists to optimize the management of these complex patients. Content Type Journal ArticleCategory Brief ReportPages 1-3DOI 10.1007/s10067-011-1845-8Authors Angela Juby, Department of Medicine, Division of Geriatric Medicine, Faculty of Medicine, University of Alberta, B139 Clinical Sciences Building, 8440 112 Street, Edmonton, AB T6G 2B7, [...]
Related posts:&lt;ol&gt;&lt;li&gt;&lt;a
href='http://www.polymyalgia-rheumatica.com/acute-pseudogout-of-the-necka%c2%80%c2%94the-crowned-dens-syndrome-2-case-reports-and-review-of-the-literature.html' rel='bookmark' title='Acute pseudogout of the neckâthe crowned dens syndrome: 2 case reports and review of the literature'&gt;Acute pseudogout of the neckâthe crowned dens syndrome: 2 case reports and review of the literature&lt;/a&gt; &lt;small&gt;We report 2 cases of crowned dens syndrome masquerading respectively as meningitis and polymyalgia rheumatica, and review the literature with...&lt;/small&gt;&lt;/li&gt;&lt;li&gt;&lt;a
href='http://www.polymyalgia-rheumatica.com/coexistence-of-the-monostatic-pageta%c2%80%c2%99s-disease-sensorimotor-neuropathy-and-elderly-onset-rheumatoid-arthritis.html' rel='bookmark' title='Coexistence of the monostatic Pagetâs disease, sensorimotor neuropathy and elderly onset rheumatoid arthritis'&gt;Coexistence of the monostatic Pagetâs disease, sensorimotor neuropathy and elderly onset rheumatoid arthritis&lt;/a&gt; &lt;small&gt;We reported a rare case of monostatic Pagetâs disease, sensorimotor neuropathy and elderly onset rheumatoid arthritis in an elderly women....&lt;/small&gt;&lt;/li&gt;&lt;li&gt;&lt;a
href='http://www.polymyalgia-rheumatica.com/the-rate-of-polymyalgia-rheumatica-pmr-and-remitting-seronegative-symmetrical-synovitis-with-pitting-edema-rs3pe-syndrome-in-a-clinic-where-primary-care-physicians-are-working-in-japan-2.html' rel='bookmark' title='The rate of polymyalgia rheumatica (PMR) and remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome in a clinic where primary care physicians are working in Japan'&gt;The rate of polymyalgia rheumatica (PMR) and remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome in a clinic where primary care physicians are working in Japan&lt;/a&gt; &lt;small&gt;Abstract&amp;nbsp;&amp;nbsp;We analyzed the rate of polymyalgia rheumatica (PMR) and remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome, both characterized...&lt;/small&gt;&lt;/li&gt;&lt;li&gt;&lt;a
href='http://www.polymyalgia-rheumatica.com/the-rate-of-polymyalgia-rheumatica-pmr-and-remitting-seronegative-symmetrical-synovitis-with-pitting-edema-rs3pe-syndrome-in-a-clinic-where-primary-care-physicians-are-working-in-japan.html' rel='bookmark' title='The rate of polymyalgia rheumatica (PMR) and remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome in a clinic where primary care physicians are working in Japan'&gt;The rate of polymyalgia rheumatica (PMR) and remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome in a clinic where primary care physicians are working in Japan&lt;/a&gt; &lt;small&gt;Abstract&amp;nbsp;&amp;nbsp;We analyzed the rate of polymyalgia rheumatica (PMR) and remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome, both characterized...&lt;/small&gt;&lt;/li&gt;&lt;li&gt;&lt;a
href='http://www.polymyalgia-rheumatica.com/fdg-petct-of-polymyalgia-rheumatica-3.html' rel='bookmark' title='FDG-PET/CT of polymyalgia rheumatica'&gt;FDG-PET/CT of polymyalgia rheumatica&lt;/a&gt; &lt;small&gt;Content Type Journal ArticlePages 1-3DOI 10.1007/s10165-010-0382-7Authors Takuya Kotani, First Department of Internal Medicine, Osaka Medical College, 2-7 Daigaku-Machi, Takatsuki, Osaka...&lt;/small&gt;&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/U9EPaHE2lnNhgZqJVgwt8JlEFfs/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/U9EPaHE2lnNhgZqJVgwt8JlEFfs/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/U9EPaHE2lnNhgZqJVgwt8JlEFfs/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/U9EPaHE2lnNhgZqJVgwt8JlEFfs/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/PolymyalgiaRheumatica/~4/IEo48Y3PUek" height="1" width="1"/&gt;</description> <wfw:commentRss>http://www.polymyalgia-rheumatica.com/an-evaluation-of-the-impact-of-seniors-on-a-rheumatology-referral-clinic-demographics-and-pharmacotherapy.html/feed/</wfw:commentRss> <slash:comments>0</slash:comments> <feedburner:origLink>http://www.polymyalgia-rheumatica.com/an-evaluation-of-the-impact-of-seniors-on-a-rheumatology-referral-clinic-demographics-and-pharmacotherapy.html</feedburner:origLink></item> <item><title>Giant cell arteritis with polymyalgia rheumatica associated with influenza vaccination</title><link>http://feedproxy.google.com/~r/PolymyalgiaRheumatica/~3/elZeDPqnOZ0/giant-cell-arteritis-with-polymyalgia-rheumatica-associated-with-influenza-vaccination.html</link> <comments>http://www.polymyalgia-rheumatica.com/giant-cell-arteritis-with-polymyalgia-rheumatica-associated-with-influenza-vaccination.html#comments</comments> <pubDate>Tue, 27 Sep 2011 05:21:34 +0000</pubDate> <dc:creator>wildplus</dc:creator> <category><![CDATA[Uncategorized]]></category> <category><![CDATA[Arteritis]]></category> <category><![CDATA[associated]]></category> <category><![CDATA[Cell]]></category> <category><![CDATA[Giant]]></category> <category><![CDATA[influenza]]></category> <category><![CDATA[Polymyalgia]]></category> <category><![CDATA[Rheumatica]]></category> <category><![CDATA[vaccination]]></category> <guid isPermaLink="false">http://www.polymyalgia-rheumatica.com/giant-cell-arteritis-with-polymyalgia-rheumatica-associated-with-influenza-vaccination</guid> <description>(Source: The Journal of Dermatology) MedWorm: Polymyalgia Rheumatica Related posts:Predictors of positive temporal artery biopsy in patients with giant cell arteritis and polymyalgia rheumatica (comment on the article by MarÃ­ et al.). Predictors of positive temporal artery biopsy in patients with giant cell arteritis and polymyalgia rheumatica (comment on the article by... Polymyalgia Rheumatica and [...]
Related posts:&lt;ol&gt;&lt;li&gt;&lt;a
href='http://www.polymyalgia-rheumatica.com/predictors-of-positive-temporal-artery-biopsy-in-patients-with-giant-cell-arteritis-and-polymyalgia-rheumatica-comment-on-the-article-by-mara%c2%ad-et-al.html' rel='bookmark' title='Predictors of positive temporal artery biopsy in patients with giant cell arteritis and polymyalgia rheumatica (comment on the article by MarÃ­ et al.).'&gt;Predictors of positive temporal artery biopsy in patients with giant cell arteritis and polymyalgia rheumatica (comment on the article by MarÃ­ et al.).&lt;/a&gt; &lt;small&gt;Predictors of positive temporal artery biopsy in patients with giant cell arteritis and polymyalgia rheumatica (comment on the article by...&lt;/small&gt;&lt;/li&gt;&lt;li&gt;&lt;a
href='http://www.polymyalgia-rheumatica.com/polymyalgia-rheumatica-and-giant-cell-arteritis-in-older-patients-diagnosis-and-pharmacological-management.html' rel='bookmark' title='Polymyalgia Rheumatica and Giant Cell Arteritis in Older Patients: Diagnosis and Pharmacological Management'&gt;Polymyalgia Rheumatica and Giant Cell Arteritis in Older Patients: Diagnosis and Pharmacological Management&lt;/a&gt; &lt;small&gt;(Source: Drugs) MedWorm Sponsor Message: Find out how you can get your message posted here and on over 100,000 other...&lt;/small&gt;&lt;/li&gt;&lt;li&gt;&lt;a
href='http://www.polymyalgia-rheumatica.com/polymyalgia-rheumatica-and-giant-cell-arteritis-3.html' rel='bookmark' title='Polymyalgia Rheumatica and Giant Cell Arteritis'&gt;Polymyalgia Rheumatica and Giant Cell Arteritis&lt;/a&gt; &lt;small&gt;(Source: Springer Medicine titles) MedWorm: Polymyalgia Rheumatica...&lt;/small&gt;&lt;/li&gt;&lt;li&gt;&lt;a
href='http://www.polymyalgia-rheumatica.com/polymyalgia-rheumatica-and-giant-cell-arteritis-polymyalgia-rheumatica-and-giant-cell-arteritis.html' rel='bookmark' title='Polymyalgia Rheumatica and Giant Cell Arteritis Polymyalgia Rheumatica and Giant Cell Arteritis'&gt;Polymyalgia Rheumatica and Giant Cell Arteritis Polymyalgia Rheumatica and Giant Cell Arteritis&lt;/a&gt; &lt;small&gt;Polymyalgia rheumatica and giant cell arteritis are related autoimmune conditions that occur primarily in older adults. This review highlights recent...&lt;/small&gt;&lt;/li&gt;&lt;li&gt;&lt;a
href='http://www.polymyalgia-rheumatica.com/polymyalgia-rheumatica-and-giant-cell-arteritis-management-of-two-diseases-of-the-elderly.html' rel='bookmark' title='Polymyalgia rheumatica and giant cell arteritis: management of two diseases of the elderly'&gt;Polymyalgia rheumatica and giant cell arteritis: management of two diseases of the elderly&lt;/a&gt; &lt;small&gt;Aging Health , August 2011, Vol. 7, No. 4, Pages 633-645. (Source: Future Medicine: Aging Health) MedWorm Sponsor Message: Find...&lt;/small&gt;&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/wwnndXtAYeyx6lif82FYGDaQcuA/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/wwnndXtAYeyx6lif82FYGDaQcuA/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/wwnndXtAYeyx6lif82FYGDaQcuA/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/wwnndXtAYeyx6lif82FYGDaQcuA/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/PolymyalgiaRheumatica/~4/elZeDPqnOZ0" height="1" width="1"/&gt;</description> <wfw:commentRss>http://www.polymyalgia-rheumatica.com/giant-cell-arteritis-with-polymyalgia-rheumatica-associated-with-influenza-vaccination.html/feed/</wfw:commentRss> <slash:comments>0</slash:comments> <feedburner:origLink>http://www.polymyalgia-rheumatica.com/giant-cell-arteritis-with-polymyalgia-rheumatica-associated-with-influenza-vaccination.html</feedburner:origLink></item> <item><title>Systematic review: Treatment of polymyalgia rheumatica</title><link>http://feedproxy.google.com/~r/PolymyalgiaRheumatica/~3/062C2h_PtuE/systematic-review-treatment-of-polymyalgia-rheumatica.html</link> <comments>http://www.polymyalgia-rheumatica.com/systematic-review-treatment-of-polymyalgia-rheumatica.html#comments</comments> <pubDate>Sun, 25 Sep 2011 03:07:32 +0000</pubDate> <dc:creator>wildplus</dc:creator> <category><![CDATA[Uncategorized]]></category> <category><![CDATA[Polymyalgia]]></category> <category><![CDATA[review]]></category> <category><![CDATA[Rheumatica]]></category> <category><![CDATA[systematic]]></category> <category><![CDATA[Treatment]]></category> <guid isPermaLink="false">http://www.polymyalgia-rheumatica.com/systematic-review-treatment-of-polymyalgia-rheumatica</guid> <description>Source: Arch Internal Med Area: News A systematic review of the evidence on treatment of polymyalgia rheumatica concludes that there is a scarcity of controlled trials and significant heterogeneity in those that exist; as a result, it is not possible to draw firm conclusions on the optimum treatment. &amp;#160; Polymyalgia rheumatica (PMR) is a syndrome [...]
Related posts:&lt;ol&gt;&lt;li&gt;&lt;a
href='http://www.polymyalgia-rheumatica.com/aortic-stiffness-in-polymyalgia-rheumatica-effects-of-steroid-treatment-3.html' rel='bookmark' title='Aortic Stiffness in Polymyalgia Rheumatica: Effects of Steroid Treatment'&gt;Aortic Stiffness in Polymyalgia Rheumatica: Effects of Steroid Treatment&lt;/a&gt; &lt;small&gt;Increased arterial stiffness and cardiovascular risk have been observed in inflammatory diseases. Polymyalgia rheumatica (PMR) is a disease which affects...&lt;/small&gt;&lt;/li&gt;&lt;li&gt;&lt;a
href='http://www.polymyalgia-rheumatica.com/aortic-stiffness-in-polymyalgia-rheumatica-effects-of-steroid-treatment.html' rel='bookmark' title='Aortic Stiffness in Polymyalgia Rheumatica: Effects of Steroid Treatment'&gt;Aortic Stiffness in Polymyalgia Rheumatica: Effects of Steroid Treatment&lt;/a&gt; &lt;small&gt;Increased arterial stiffness and cardiovascular risk have been observed in inflammatory diseases. Polymyalgia rheumatica (PMR) is a disease which affects...&lt;/small&gt;&lt;/li&gt;&lt;li&gt;&lt;a
href='http://www.polymyalgia-rheumatica.com/aortic-stiffness-in-polymyalgia-rheumatica-effects-of-steroid-treatment-2.html' rel='bookmark' title='Aortic Stiffness in Polymyalgia Rheumatica: Effects of Steroid Treatment'&gt;Aortic Stiffness in Polymyalgia Rheumatica: Effects of Steroid Treatment&lt;/a&gt; &lt;small&gt;Increased arterial stiffness and cardiovascular risk have been observed in inflammatory diseases. Polymyalgia rheumatica (PMR) is a disease which affects...&lt;/small&gt;&lt;/li&gt;&lt;li&gt;&lt;a
href='http://www.polymyalgia-rheumatica.com/definition-of-remission-and-relapse-in-polymyalgia-rheumatica-data-from-a-literature-search-compared-with-a-delphi-based-expert-consensus.html' rel='bookmark' title='Definition of remission and relapse in polymyalgia rheumatica: data from a literature search compared with a Delphi-based expert consensus'&gt;Definition of remission and relapse in polymyalgia rheumatica: data from a literature search compared with a Delphi-based expert consensus&lt;/a&gt; &lt;small&gt;Conclusions Assessment of patient&amp;#8217;s pain, MS, ESR, CRP, shoulder pain/limitation on clinical examination and corticosteroid dose are considered to be...&lt;/small&gt;&lt;/li&gt;&lt;li&gt;&lt;a
href='http://www.polymyalgia-rheumatica.com/diagnostic-performance-of-18f-fluorodeoxyglucose-positron-emission-tomography-in-giant-cell-arteritis-a-systematic-review-and-meta-analysis.html' rel='bookmark' title='Diagnostic performance of 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a systematic review and meta-analysis'&gt;Diagnostic performance of 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a systematic review and meta-analysis&lt;/a&gt; &lt;small&gt;Conclusion&amp;nbsp;&amp;nbsp;We found overall valuable diagnostic performances for FDG PET against reference criteria. Standardized FDG uptake criteria are needed to optimize...&lt;/small&gt;&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/nNqqts0Ao6lXFUZZt2-pZCYJbak/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/nNqqts0Ao6lXFUZZt2-pZCYJbak/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/nNqqts0Ao6lXFUZZt2-pZCYJbak/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/nNqqts0Ao6lXFUZZt2-pZCYJbak/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/PolymyalgiaRheumatica/~4/062C2h_PtuE" height="1" width="1"/&gt;</description> <wfw:commentRss>http://www.polymyalgia-rheumatica.com/systematic-review-treatment-of-polymyalgia-rheumatica.html/feed/</wfw:commentRss> <slash:comments>0</slash:comments> <feedburner:origLink>http://www.polymyalgia-rheumatica.com/systematic-review-treatment-of-polymyalgia-rheumatica.html</feedburner:origLink></item> <item><title>Myelodysplastic Syndrome and Autoimmunity: A Case Report of an Unusual Presentation of Myelodysplastic Syndrome</title><link>http://feedproxy.google.com/~r/PolymyalgiaRheumatica/~3/lrWo7lPUSEE/myelodysplastic-syndrome-and-autoimmunity-a-case-report-of-an-unusual-presentation-of-myelodysplastic-syndrome.html</link> <comments>http://www.polymyalgia-rheumatica.com/myelodysplastic-syndrome-and-autoimmunity-a-case-report-of-an-unusual-presentation-of-myelodysplastic-syndrome.html#comments</comments> <pubDate>Fri, 23 Sep 2011 01:07:35 +0000</pubDate> <dc:creator>wildplus</dc:creator> <category><![CDATA[Uncategorized]]></category> <category><![CDATA[Autoimmunity]]></category> <category><![CDATA[case]]></category> <category><![CDATA[Myelodysplastic]]></category> <category><![CDATA[Presentation]]></category> <category><![CDATA[Report]]></category> <category><![CDATA[syndrome]]></category> <category><![CDATA[Unusual]]></category> <guid isPermaLink="false">http://www.polymyalgia-rheumatica.com/myelodysplastic-syndrome-and-autoimmunity-a-case-report-of-an-unusual-presentation-of-myelodysplastic-syndrome</guid> <description>We present the case of a woman with MDS (karyotype 46,XX,+1,der(1;7)(q10;p10)[20], that evolved with an additional trisomy 8 clone) and a novel spectrum of autoimmune diseases including acute fibrinous and organizing pneumonia (AFOP) and lacrimal gland pseudotumor. (Source: Gastroenterology Research and Practice) MedWorm Sponsor Message: Find out how you can get your message posted here [...]
Related posts:&lt;ol&gt;&lt;li&gt;&lt;a
href='http://www.polymyalgia-rheumatica.com/case-report-dissecting-aortic-aneurysm-of-a-patient-with-suspected-polymyalgia-rheumatica-2.html' rel='bookmark' title='Case report Dissecting aortic aneurysm of a patient with suspected polymyalgia rheumatica'&gt;Case report Dissecting aortic aneurysm of a patient with suspected polymyalgia rheumatica&lt;/a&gt; &lt;small&gt;A 62-year old patient was admitted to the rheumatology ward because of weakness, easy fatigue, fever, pain of the shoulder...&lt;/small&gt;&lt;/li&gt;&lt;li&gt;&lt;a
href='http://www.polymyalgia-rheumatica.com/autoimmunity-and-the-risk-of-myeloproliferative-neoplasms.html' rel='bookmark' title='Autoimmunity and the risk of myeloproliferative neoplasms.'&gt;Autoimmunity and the risk of myeloproliferative neoplasms.&lt;/a&gt; &lt;small&gt;Authors: Kristinsson SY, Landgren O, Samuelsson J, Bj&amp;#xF6;rkholm M, Goldin LR The causes of myeloproliferative neoplasm (MPN) are unknown. We...&lt;/small&gt;&lt;/li&gt;&lt;li&gt;&lt;a
href='http://www.polymyalgia-rheumatica.com/case-report-the-patient-has-the-diagnosis.html' rel='bookmark' title='[Case Report] The patient has the diagnosis'&gt;[Case Report] The patient has the diagnosis&lt;/a&gt; &lt;small&gt;In October, 2009, a 59-year-old man from the Balearic Islands, Spain, was referred to our department with a 10-month history...&lt;/small&gt;&lt;/li&gt;&lt;li&gt;&lt;a
href='http://www.polymyalgia-rheumatica.com/giant-cell-arteritis-of-the-female-genital-tract-report-of-a-case-and-review-of-the-literature-case-report-an-article-from-southern-medical-journal.html' rel='bookmark' title='Giant cell arteritis of the female genital tract: report of a case and review of the literature.(Case Report): An article from: Southern Medical Journal'&gt;Giant cell arteritis of the female genital tract: report of a case and review of the literature.(Case Report): An article from: Southern Medical Journal&lt;/a&gt; &lt;small&gt;Giant cell arteritis of the female genital tract: report of a case and review of the literature.(Case Report): An article...&lt;/small&gt;&lt;/li&gt;&lt;li&gt;&lt;a
href='http://www.polymyalgia-rheumatica.com/Case-report-Dissecting-aortic-aneurysm-of-a-patient-with-suspected-polymyalgia-rheumatica.html' rel='bookmark' title='Case report Dissecting aortic aneurysm of a patient with suspected polymyalgia rheumatica'&gt;Case report Dissecting aortic aneurysm of a patient with suspected polymyalgia rheumatica&lt;/a&gt; &lt;small&gt;A 62-year old patient was admitted to the rheumatology ward because of weakness, easy fatigue, fever, pain of the shoulder...&lt;/small&gt;&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/Et7oRcT4ozAkKYRP7LBhdfkhVxM/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/Et7oRcT4ozAkKYRP7LBhdfkhVxM/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/Et7oRcT4ozAkKYRP7LBhdfkhVxM/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/Et7oRcT4ozAkKYRP7LBhdfkhVxM/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/PolymyalgiaRheumatica/~4/lrWo7lPUSEE" height="1" width="1"/&gt;</description> <wfw:commentRss>http://www.polymyalgia-rheumatica.com/myelodysplastic-syndrome-and-autoimmunity-a-case-report-of-an-unusual-presentation-of-myelodysplastic-syndrome.html/feed/</wfw:commentRss> <slash:comments>0</slash:comments> <feedburner:origLink>http://www.polymyalgia-rheumatica.com/myelodysplastic-syndrome-and-autoimmunity-a-case-report-of-an-unusual-presentation-of-myelodysplastic-syndrome.html</feedburner:origLink></item> <item><title>Adverse events of low- to medium-dose oral glucocorticoids in inflammatory diseases: a meta-analysis</title><link>http://feedproxy.google.com/~r/PolymyalgiaRheumatica/~3/FBYPU3i8_a8/adverse-events-of-low-to-medium-dose-oral-glucocorticoids-in-inflammatory-diseases-a-meta-analysis.html</link> <comments>http://www.polymyalgia-rheumatica.com/adverse-events-of-low-to-medium-dose-oral-glucocorticoids-in-inflammatory-diseases-a-meta-analysis.html#comments</comments> <pubDate>Tue, 20 Sep 2011 23:06:50 +0000</pubDate> <dc:creator>wildplus</dc:creator> <category><![CDATA[Uncategorized]]></category> <category><![CDATA[Adverse]]></category> <category><![CDATA[Diseases]]></category> <category><![CDATA[events]]></category> <category><![CDATA[glucocorticoids]]></category> <category><![CDATA[inflammatory]]></category> <category><![CDATA[mediumdose]]></category> <category><![CDATA[metaanalysis]]></category> <category><![CDATA[oral]]></category> <guid isPermaLink="false">http://www.polymyalgia-rheumatica.com/adverse-events-of-low-to-medium-dose-oral-glucocorticoids-in-inflammatory-diseases-a-meta-analysis</guid> <description>Conclusions: The risk of adverse events depends on study design and disease. Studies on inflammatory bowel disease were often of short duration with frequent documentation of adverse events which resulted in higher adverse event rates whereas, in studies of rheumatoid arthritis, the longer follow-up may have resulted in lower adverse event rates. In most studies [...]
Related posts:&lt;ol&gt;&lt;li&gt;&lt;a
href='http://www.polymyalgia-rheumatica.com/the-lifetime-risk-of-adulta%c2%80%c2%90onset-rheumatoid-arthritis-and-other-inflammatory-autoimmune-rheumatic-diseases-3.html' rel='bookmark' title='The lifetime risk of adultâonset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases'&gt;The lifetime risk of adultâonset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases&lt;/a&gt; &lt;small&gt;Conclusion:One in 12 women and 1 in 20 men will develop inflammatory autoimmune rheumatic disease during their lifetime. These results...&lt;/small&gt;&lt;/li&gt;&lt;li&gt;&lt;a
href='http://www.polymyalgia-rheumatica.com/the-lifetime-risk-of-adulta%c2%80%c2%90onset-rheumatoid-arthritis-and-other-inflammatory-autoimmune-rheumatic-diseases.html' rel='bookmark' title='The lifetime risk of adultâonset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases'&gt;The lifetime risk of adultâonset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases&lt;/a&gt; &lt;small&gt;Conclusion:One in 12 women and 1 in 20 men will develop inflammatory autoimmune rheumatic disease during their lifetime. These results...&lt;/small&gt;&lt;/li&gt;&lt;li&gt;&lt;a
href='http://www.polymyalgia-rheumatica.com/the-lifetime-risk-of-adulta%c2%80%c2%90onset-rheumatoid-arthritis-and-other-inflammatory-autoimmune-rheumatic-diseases-2.html' rel='bookmark' title='The lifetime risk of adultâonset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases'&gt;The lifetime risk of adultâonset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases&lt;/a&gt; &lt;small&gt;Conclusion:One in 12 women and 1 in 20 men will develop inflammatory autoimmune rheumatic disease during their lifetime. These results...&lt;/small&gt;&lt;/li&gt;&lt;li&gt;&lt;a
href='http://www.polymyalgia-rheumatica.com/diagnostic-performance-of-18f-fluorodeoxyglucose-positron-emission-tomography-in-giant-cell-arteritis-a-systematic-review-and-meta-analysis.html' rel='bookmark' title='Diagnostic performance of 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a systematic review and meta-analysis'&gt;Diagnostic performance of 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a systematic review and meta-analysis&lt;/a&gt; &lt;small&gt;Conclusion&amp;nbsp;&amp;nbsp;We found overall valuable diagnostic performances for FDG PET against reference criteria. Standardized FDG uptake criteria are needed to optimize...&lt;/small&gt;&lt;/li&gt;&lt;li&gt;&lt;a
href='http://www.polymyalgia-rheumatica.com/vytorin%c2%ae-ezetimibesimvastatin-significantly-reduced-major-vascular-events-in-patients-with-chronic-kidney-disease.html' rel='bookmark' title='VYTORIN® (ezetimibe/simvastatin) Significantly Reduced Major Vascular Events in Patients With Chronic Kidney Disease &amp;#8230;'&gt;VYTORIN® (ezetimibe/simvastatin) Significantly Reduced Major Vascular Events in Patients With Chronic Kidney Disease &amp;#8230;&lt;/a&gt; &lt;small&gt;VYTORIN® (ezetimibe/simvastatin) Significantly Reduced Major Vascular Events in Patients With Chronic Kidney Disease &amp;#8230; In a new investigational study of...&lt;/small&gt;&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/IEy6-19-jbUB8me7v-nip2-8F6Q/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/IEy6-19-jbUB8me7v-nip2-8F6Q/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/IEy6-19-jbUB8me7v-nip2-8F6Q/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/IEy6-19-jbUB8me7v-nip2-8F6Q/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/PolymyalgiaRheumatica/~4/FBYPU3i8_a8" height="1" width="1"/&gt;</description> <wfw:commentRss>http://www.polymyalgia-rheumatica.com/adverse-events-of-low-to-medium-dose-oral-glucocorticoids-in-inflammatory-diseases-a-meta-analysis.html/feed/</wfw:commentRss> <slash:comments>0</slash:comments> <feedburner:origLink>http://www.polymyalgia-rheumatica.com/adverse-events-of-low-to-medium-dose-oral-glucocorticoids-in-inflammatory-diseases-a-meta-analysis.html</feedburner:origLink></item> <item><title>The clinical course of polymyalgia rheumatica in Chinese</title><link>http://feedproxy.google.com/~r/PolymyalgiaRheumatica/~3/FG1_h1fZUA0/the-clinical-course-of-polymyalgia-rheumatica-in-chinese-2.html</link> <comments>http://www.polymyalgia-rheumatica.com/the-clinical-course-of-polymyalgia-rheumatica-in-chinese-2.html#comments</comments> <pubDate>Sun, 18 Sep 2011 21:06:22 +0000</pubDate> <dc:creator>wildplus</dc:creator> <category><![CDATA[Uncategorized]]></category> <category><![CDATA[Chinese]]></category> <category><![CDATA[Clinical]]></category> <category><![CDATA[Course]]></category> <category><![CDATA[Polymyalgia]]></category> <category><![CDATA[Rheumatica]]></category> <guid isPermaLink="false">http://www.polymyalgia-rheumatica.com/the-clinical-course-of-polymyalgia-rheumatica-in-chinese-2</guid> <description>Abstract&amp;#160;&amp;#160;Polymyalgia rheumatica (PMR) is diagnosed based on clinical features that may overlap with other rheumatic conditions like rheumatoid arthritis (RA). Furthermore, a proportion of PMR patients may subsequently evolve into RA. The aim of this study was to examine the clinical characteristics of PMR patients in a Chinese cohort compared to a Caucasian series. Patients [...]
Related posts:&lt;ol&gt;&lt;li&gt;&lt;a
href='http://www.polymyalgia-rheumatica.com/The-clinical-course-of-polymyalgia-rheumatica-in-Chinese.html' rel='bookmark' title='The clinical course of polymyalgia rheumatica in Chinese'&gt;The clinical course of polymyalgia rheumatica in Chinese&lt;/a&gt; &lt;small&gt;Abstract&amp;nbsp;&amp;nbsp;Polymyalgia rheumatica (PMR) is diagnosed based on clinical features that may overlap with other rheumatic conditions like rheumatoid arthritis (RA)....&lt;/small&gt;&lt;/li&gt;&lt;li&gt;&lt;a
href='http://www.polymyalgia-rheumatica.com/temporal-small-vessel-inflammation-in-patients-with-giant-cell-arteritis-clinical-course-and-preliminary-immunohistopathologic-characterization-3.html' rel='bookmark' title='Temporal Small-Vessel Inflammation in Patients with Giant Cell Arteritis: Clinical Course and Preliminary Immunohistopathologic Characterization.'&gt;Temporal Small-Vessel Inflammation in Patients with Giant Cell Arteritis: Clinical Course and Preliminary Immunohistopathologic Characterization.&lt;/a&gt; &lt;small&gt;CONCLUSION: A significant number of patients with clinical features of GCA demonstrated isolated TSVI. Differences in the clinical presentation and...&lt;/small&gt;&lt;/li&gt;&lt;li&gt;&lt;a
href='http://www.polymyalgia-rheumatica.com/temporal-small-vessel-inflammation-in-patients-with-giant-cell-arteritis-clinical-course-and-preliminary-immunohistopathologic-characterization.html' rel='bookmark' title='Temporal Small-Vessel Inflammation in Patients with Giant Cell Arteritis: Clinical Course and Preliminary Immunohistopathologic Characterization.'&gt;Temporal Small-Vessel Inflammation in Patients with Giant Cell Arteritis: Clinical Course and Preliminary Immunohistopathologic Characterization.&lt;/a&gt; &lt;small&gt;CONCLUSION: A significant number of patients with clinical features of GCA demonstrated isolated TSVI. Differences in the clinical presentation and...&lt;/small&gt;&lt;/li&gt;&lt;li&gt;&lt;a
href='http://www.polymyalgia-rheumatica.com/temporal-small-vessel-inflammation-in-patients-with-giant-cell-arteritis-clinical-course-and-preliminary-immunohistopathologic-characterization-2.html' rel='bookmark' title='Temporal Small-Vessel Inflammation in Patients with Giant Cell Arteritis: Clinical Course and Preliminary Immunohistopathologic Characterization.'&gt;Temporal Small-Vessel Inflammation in Patients with Giant Cell Arteritis: Clinical Course and Preliminary Immunohistopathologic Characterization.&lt;/a&gt; &lt;small&gt;CONCLUSION: A significant number of patients with clinical features of GCA demonstrated isolated TSVI. Differences in the clinical presentation and...&lt;/small&gt;&lt;/li&gt;&lt;li&gt;&lt;a
href='http://www.polymyalgia-rheumatica.com/21st-century-complete-medical-guide-to-temporal-arteritis-and-polymyalgia-rheumatica-authoritative-government-documents-clinical-information-for-patients-and-physicians.html' rel='bookmark' title='21st Century Complete Medical Guide to Temporal Arteritis  and Polymyalgia Rheumatica: Authoritative Government Documents, Clinical &amp;#8230; Information for Patients and Physicians'&gt;21st Century Complete Medical Guide to Temporal Arteritis  and Polymyalgia Rheumatica: Authoritative Government Documents, Clinical &amp;#8230; Information for Patients and Physicians&lt;/a&gt; &lt;small&gt;Product DescriptionThis up-to-date electronic book on CD-ROM provides the best collection available anywhere of official Federal government information and documents...&lt;/small&gt;&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/cueT4IwSXd3biED9thiryyRmimI/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/cueT4IwSXd3biED9thiryyRmimI/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/cueT4IwSXd3biED9thiryyRmimI/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/cueT4IwSXd3biED9thiryyRmimI/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/PolymyalgiaRheumatica/~4/FG1_h1fZUA0" height="1" width="1"/&gt;</description> <wfw:commentRss>http://www.polymyalgia-rheumatica.com/the-clinical-course-of-polymyalgia-rheumatica-in-chinese-2.html/feed/</wfw:commentRss> <slash:comments>0</slash:comments> <feedburner:origLink>http://www.polymyalgia-rheumatica.com/the-clinical-course-of-polymyalgia-rheumatica-in-chinese-2.html</feedburner:origLink></item> <item><title>Polymyalgia Rheumatica and Giant Cell Arteritis Polymyalgia Rheumatica and Giant Cell Arteritis</title><link>http://feedproxy.google.com/~r/PolymyalgiaRheumatica/~3/VPMQfW8A5RE/polymyalgia-rheumatica-and-giant-cell-arteritis-polymyalgia-rheumatica-and-giant-cell-arteritis.html</link> <comments>http://www.polymyalgia-rheumatica.com/polymyalgia-rheumatica-and-giant-cell-arteritis-polymyalgia-rheumatica-and-giant-cell-arteritis.html#comments</comments> <pubDate>Fri, 16 Sep 2011 19:09:29 +0000</pubDate> <dc:creator>wildplus</dc:creator> <category><![CDATA[Uncategorized]]></category> <category><![CDATA[Arteritis]]></category> <category><![CDATA[Cell]]></category> <category><![CDATA[Giant]]></category> <category><![CDATA[Polymyalgia]]></category> <category><![CDATA[Rheumatica]]></category> <guid isPermaLink="false">http://www.polymyalgia-rheumatica.com/polymyalgia-rheumatica-and-giant-cell-arteritis-polymyalgia-rheumatica-and-giant-cell-arteritis</guid> <description>Polymyalgia rheumatica and giant cell arteritis are related autoimmune conditions that occur primarily in older adults. This review highlights recent advances in their diagnosis and management. Aging Health (Source: Medscape Today Headlines) MedWorm Sponsor Message: Find out how you can get your message posted here and on over 100,000 other medical web pages in just [...]
Related posts:&lt;ol&gt;&lt;li&gt;&lt;a
href='http://www.polymyalgia-rheumatica.com/current-understanding-and-management-of-giant-cell-arteritis-and-polymyalgia-rheumatica-4.html' rel='bookmark' title='Current Understanding and Management of Giant Cell Arteritis and Polymyalgia Rheumatica'&gt;Current Understanding and Management of Giant Cell Arteritis and Polymyalgia Rheumatica&lt;/a&gt; &lt;small&gt;This article reviews recent guidelines on early diagnosis, investigations and management of these two diseases impacting the elderly. Expert Review...&lt;/small&gt;&lt;/li&gt;&lt;li&gt;&lt;a
href='http://www.polymyalgia-rheumatica.com/current-understanding-and-management-of-giant-cell-arteritis-and-polymyalgia-rheumatica-2.html' rel='bookmark' title='Current Understanding and Management of Giant Cell Arteritis and Polymyalgia Rheumatica'&gt;Current Understanding and Management of Giant Cell Arteritis and Polymyalgia Rheumatica&lt;/a&gt; &lt;small&gt;This article reviews recent guidelines on early diagnosis, investigations and management of these two diseases impacting the elderly. Expert Review...&lt;/small&gt;&lt;/li&gt;&lt;li&gt;&lt;a
href='http://www.polymyalgia-rheumatica.com/current-understanding-and-management-of-giant-cell-arteritis-and-polymyalgia-rheumatica-3.html' rel='bookmark' title='Current Understanding and Management of Giant Cell Arteritis and Polymyalgia Rheumatica'&gt;Current Understanding and Management of Giant Cell Arteritis and Polymyalgia Rheumatica&lt;/a&gt; &lt;small&gt;This article reviews recent guidelines on early diagnosis, investigations and management of these two diseases impacting the elderly. Expert Review...&lt;/small&gt;&lt;/li&gt;&lt;li&gt;&lt;a
href='http://www.polymyalgia-rheumatica.com/current-understanding-and-management-of-giant-cell-arteritis-and-polymyalgia-rheumatica.html' rel='bookmark' title='Current Understanding and Management of Giant Cell Arteritis and Polymyalgia Rheumatica'&gt;Current Understanding and Management of Giant Cell Arteritis and Polymyalgia Rheumatica&lt;/a&gt; &lt;small&gt;This article reviews recent guidelines on early diagnosis, investigations and management of these two diseases impacting the elderly. Expert Review...&lt;/small&gt;&lt;/li&gt;&lt;li&gt;&lt;a
href='http://www.polymyalgia-rheumatica.com/polymyalgia-rheumatica-and-giant-cell-arteritis-management-of-two-diseases-of-the-elderly.html' rel='bookmark' title='Polymyalgia rheumatica and giant cell arteritis: management of two diseases of the elderly'&gt;Polymyalgia rheumatica and giant cell arteritis: management of two diseases of the elderly&lt;/a&gt; &lt;small&gt;Aging Health , August 2011, Vol. 7, No. 4, Pages 633-645. (Source: Future Medicine: Aging Health) MedWorm Sponsor Message: Find...&lt;/small&gt;&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/O7xev2vvaWfcSmn4akIZ-KzIEzY/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/O7xev2vvaWfcSmn4akIZ-KzIEzY/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/O7xev2vvaWfcSmn4akIZ-KzIEzY/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/O7xev2vvaWfcSmn4akIZ-KzIEzY/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/PolymyalgiaRheumatica/~4/VPMQfW8A5RE" height="1" width="1"/&gt;</description> <wfw:commentRss>http://www.polymyalgia-rheumatica.com/polymyalgia-rheumatica-and-giant-cell-arteritis-polymyalgia-rheumatica-and-giant-cell-arteritis.html/feed/</wfw:commentRss> <slash:comments>0</slash:comments> <feedburner:origLink>http://www.polymyalgia-rheumatica.com/polymyalgia-rheumatica-and-giant-cell-arteritis-polymyalgia-rheumatica-and-giant-cell-arteritis.html</feedburner:origLink></item> <item><title>Lack of Association Between IRF5 Gene Polymorphisms and Biopsy-proven Giant Cell Arteritis.</title><link>http://feedproxy.google.com/~r/PolymyalgiaRheumatica/~3/OBCY7CV6uLk/lack-of-association-between-irf5-gene-polymorphisms-and-biopsy-proven-giant-cell-arteritis.html</link> <comments>http://www.polymyalgia-rheumatica.com/lack-of-association-between-irf5-gene-polymorphisms-and-biopsy-proven-giant-cell-arteritis.html#comments</comments> <pubDate>Mon, 12 Sep 2011 15:06:25 +0000</pubDate> <dc:creator>wildplus</dc:creator> <category><![CDATA[Uncategorized]]></category> <category><![CDATA[Arteritis]]></category> <category><![CDATA[association]]></category> <category><![CDATA[Between]]></category> <category><![CDATA[Biopsyproven]]></category> <category><![CDATA[Cell]]></category> <category><![CDATA[Gene]]></category> <category><![CDATA[Giant]]></category> <category><![CDATA[IRF5]]></category> <category><![CDATA[Lack]]></category> <category><![CDATA[Polymorphisms]]></category> <guid isPermaLink="false">http://www.polymyalgia-rheumatica.com/lack-of-association-between-irf5-gene-polymorphisms-and-biopsy-proven-giant-cell-arteritis</guid> <description>CONCLUSION: Our results showed no association of IRF5 rs2004640 and CGGGG insertion/deletion polymorphisms in the susceptibility to and clinical expression of GCA. PMID: 19918036 [PubMed - as supplied by publisher] (Source: J Rheumatol) MedWorm Sponsor Message: Find out how you can get your message posted here and on over 100,000 other medical web pages in [...]
Related posts:&lt;ol&gt;&lt;li&gt;&lt;a
href='http://www.polymyalgia-rheumatica.com/lack-of-association-between-the-rs6920220-ga-polymorphism-of-the-6q23-region-and-biopsy-proven-giant-cell-arteritis.html' rel='bookmark' title='Lack of Association Between the rs6920220 (G/A) Polymorphism of the 6q23 Region and Biopsy-proven Giant Cell Arteritis.'&gt;Lack of Association Between the rs6920220 (G/A) Polymorphism of the 6q23 Region and Biopsy-proven Giant Cell Arteritis.&lt;/a&gt; &lt;small&gt;CONCLUSION: Our results show no involvement of this 6q23/TNFAIP3 gene region SNP in the susceptibility to or clinical expression of...&lt;/small&gt;&lt;/li&gt;&lt;li&gt;&lt;a
href='http://www.polymyalgia-rheumatica.com/influence-of-il2ra-rs2104286-polymorphism-in-the-risk-of-biopsy-proven-giant-cell-arteritis-2.html' rel='bookmark' title='Influence of IL2RA rs2104286 Polymorphism in the Risk of Biopsy-proven Giant Cell Arteritis.'&gt;Influence of IL2RA rs2104286 Polymorphism in the Risk of Biopsy-proven Giant Cell Arteritis.&lt;/a&gt; &lt;small&gt;CONCLUSION: IL2RA rs2104286 polymorphism does not appear to be a genetic risk factor for susceptibility to biopsy-proven GCA. Also, this...&lt;/small&gt;&lt;/li&gt;&lt;li&gt;&lt;a
href='http://www.polymyalgia-rheumatica.com/influence-of-il2ra-rs2104286-polymorphism-in-the-risk-of-biopsy-proven-giant-cell-arteritis.html' rel='bookmark' title='Influence of IL2RA rs2104286 Polymorphism in the Risk of Biopsy-proven Giant Cell Arteritis.'&gt;Influence of IL2RA rs2104286 Polymorphism in the Risk of Biopsy-proven Giant Cell Arteritis.&lt;/a&gt; &lt;small&gt;CONCLUSION: IL2RA rs2104286 polymorphism does not appear to be a genetic risk factor for susceptibility to biopsy-proven GCA. Also, this...&lt;/small&gt;&lt;/li&gt;&lt;li&gt;&lt;a
href='http://www.polymyalgia-rheumatica.com/influence-of-il2ra-rs2104286-polymorphism-in-the-risk-of-biopsy-proven-giant-cell-arteritis-3.html' rel='bookmark' title='Influence of IL2RA rs2104286 Polymorphism in the Risk of Biopsy-proven Giant Cell Arteritis.'&gt;Influence of IL2RA rs2104286 Polymorphism in the Risk of Biopsy-proven Giant Cell Arteritis.&lt;/a&gt; &lt;small&gt;CONCLUSION: IL2RA rs2104286 polymorphism does not appear to be a genetic risk factor for susceptibility to biopsy-proven GCA. Also, this...&lt;/small&gt;&lt;/li&gt;&lt;li&gt;&lt;a
href='http://www.polymyalgia-rheumatica.com/temporal-small-vessel-inflammation-in-patients-with-giant-cell-arteritis-clinical-course-and-preliminary-immunohistopathologic-characterization-3.html' rel='bookmark' title='Temporal Small-Vessel Inflammation in Patients with Giant Cell Arteritis: Clinical Course and Preliminary Immunohistopathologic Characterization.'&gt;Temporal Small-Vessel Inflammation in Patients with Giant Cell Arteritis: Clinical Course and Preliminary Immunohistopathologic Characterization.&lt;/a&gt; &lt;small&gt;CONCLUSION: A significant number of patients with clinical features of GCA demonstrated isolated TSVI. Differences in the clinical presentation and...&lt;/small&gt;&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/ALtkteIJvs0uH8ynzE8q4hLER10/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/ALtkteIJvs0uH8ynzE8q4hLER10/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/ALtkteIJvs0uH8ynzE8q4hLER10/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/ALtkteIJvs0uH8ynzE8q4hLER10/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/PolymyalgiaRheumatica/~4/OBCY7CV6uLk" height="1" width="1"/&gt;</description> <wfw:commentRss>http://www.polymyalgia-rheumatica.com/lack-of-association-between-irf5-gene-polymorphisms-and-biopsy-proven-giant-cell-arteritis.html/feed/</wfw:commentRss> <slash:comments>0</slash:comments> <feedburner:origLink>http://www.polymyalgia-rheumatica.com/lack-of-association-between-irf5-gene-polymorphisms-and-biopsy-proven-giant-cell-arteritis.html</feedburner:origLink></item> <item><title>Longitudinal examination with shoulder ultrasound of patients with polymyalgia rheumatica</title><link>http://feedproxy.google.com/~r/PolymyalgiaRheumatica/~3/xOFMR4AEhV0/longitudinal-examination-with-shoulder-ultrasound-of-patients-with-polymyalgia-rheumatica-2.html</link> <comments>http://www.polymyalgia-rheumatica.com/longitudinal-examination-with-shoulder-ultrasound-of-patients-with-polymyalgia-rheumatica-2.html#comments</comments> <pubDate>Sat, 10 Sep 2011 13:10:07 +0000</pubDate> <dc:creator>wildplus</dc:creator> <category><![CDATA[Uncategorized]]></category> <category><![CDATA[examination]]></category> <category><![CDATA[Longitudinal]]></category> <category><![CDATA[Patient's]]></category> <category><![CDATA[Polymyalgia]]></category> <category><![CDATA[Rheumatica]]></category> <category><![CDATA[Shoulder]]></category> <category><![CDATA[ultrasound]]></category> <guid isPermaLink="false">http://www.polymyalgia-rheumatica.com/longitudinal-examination-with-shoulder-ultrasound-of-patients-with-polymyalgia-rheumatica-2</guid> <description>Conclusion. Subclinical inflammation detected by US persists in most PMR patients despite glucocorticoid treatment. PDUS may be useful to detect at diagnosis the patients with most active inflammation who have a higher risk of relapses/recurrences. (Source: Rheumatology) MedWorm: Polymyalgia Rheumatica Related posts:Longitudinal examination with shoulder ultrasound of patients with polymyalgia rheumatica Conclusion. Subclinical inflammation detected [...]
Related posts:&lt;ol&gt;&lt;li&gt;&lt;a
href='http://www.polymyalgia-rheumatica.com/Longitudinal-examination-with-shoulder-ultrasound-of-patients-with-polymyalgia-rheumatica.html' rel='bookmark' title='Longitudinal examination with shoulder ultrasound of patients with polymyalgia rheumatica'&gt;Longitudinal examination with shoulder ultrasound of patients with polymyalgia rheumatica&lt;/a&gt; &lt;small&gt;Conclusion. Subclinical inflammation detected by US persists in most PMR patients despite glucocorticoid treatment. PDUS may be useful to detect...&lt;/small&gt;&lt;/li&gt;&lt;li&gt;&lt;a
href='http://www.polymyalgia-rheumatica.com/comment-on-longitudinal-examination-with-shoulder-ultrasound-in-patients-with-polymyalgia-rheumatica-2.html' rel='bookmark' title='Comment on: Longitudinal examination with shoulder ultrasound in patients with polymyalgia rheumatica'&gt;Comment on: Longitudinal examination with shoulder ultrasound in patients with polymyalgia rheumatica&lt;/a&gt; &lt;small&gt;(Source: Rheumatology) MedWorm Sponsor Message: Watch the new MedWorm demo and find out how to get all the very latest,...&lt;/small&gt;&lt;/li&gt;&lt;li&gt;&lt;a
href='http://www.polymyalgia-rheumatica.com/comment-on-longitudinal-examination-with-shoulder-ultrasound-in-patients-with-polymyalgia-rheumatica-reply-2.html' rel='bookmark' title='Comment on: Longitudinal examination with shoulder ultrasound in patients with polymyalgia rheumatica: reply'&gt;Comment on: Longitudinal examination with shoulder ultrasound in patients with polymyalgia rheumatica: reply&lt;/a&gt; &lt;small&gt;(Source: Rheumatology) MedWorm: Polymyalgia Rheumatica...&lt;/small&gt;&lt;/li&gt;&lt;li&gt;&lt;a
href='http://www.polymyalgia-rheumatica.com/comment-on-longitudinal-examination-with-shoulder-ultrasound-in-patients-with-polymyalgia-rheumatica.html' rel='bookmark' title='Comment on: Longitudinal examination with shoulder ultrasound in patients with polymyalgia rheumatica'&gt;Comment on: Longitudinal examination with shoulder ultrasound in patients with polymyalgia rheumatica&lt;/a&gt; &lt;small&gt;(Source: Rheumatology) MedWorm Sponsor Message: Watch the new MedWorm demo and find out how to get all the very latest,...&lt;/small&gt;&lt;/li&gt;&lt;li&gt;&lt;a
href='http://www.polymyalgia-rheumatica.com/comment-on-longitudinal-examination-with-shoulder-ultrasound-in-patients-with-polymyalgia-rheumatica-3.html' rel='bookmark' title='Comment on: Longitudinal examination with shoulder ultrasound in patients with polymyalgia rheumatica'&gt;Comment on: Longitudinal examination with shoulder ultrasound in patients with polymyalgia rheumatica&lt;/a&gt; &lt;small&gt;(Source: Rheumatology) MedWorm: Polymyalgia Rheumatica...&lt;/small&gt;&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/S-mO3HpQHY7IBaZd9Qd1TsRQYvw/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/S-mO3HpQHY7IBaZd9Qd1TsRQYvw/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/S-mO3HpQHY7IBaZd9Qd1TsRQYvw/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/S-mO3HpQHY7IBaZd9Qd1TsRQYvw/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/PolymyalgiaRheumatica/~4/xOFMR4AEhV0" height="1" width="1"/&gt;</description> <wfw:commentRss>http://www.polymyalgia-rheumatica.com/longitudinal-examination-with-shoulder-ultrasound-of-patients-with-polymyalgia-rheumatica-2.html/feed/</wfw:commentRss> <slash:comments>0</slash:comments> <feedburner:origLink>http://www.polymyalgia-rheumatica.com/longitudinal-examination-with-shoulder-ultrasound-of-patients-with-polymyalgia-rheumatica-2.html</feedburner:origLink></item> </channel> </rss>

